SOMAPACITAN
somapacitan 15 mg/1.5 mL injection, 1.5 mL pen device
SOMAPACITAN (15374E)
15374E
Manner of administration:Injection
Restriction
Indication: Short stature associated with biochemical growth hormone deficiency
Treatment phase: Initial treatment
Restriction
Indication: Short stature associated with biochemical growth hormone deficiency
Treatment phase: Recommencement of treatment
Restriction
Indication: Short stature associated with biochemical growth hormone deficiency
Treatment phase: Recommencement of treatment as a reclassified patient
Restriction
Indication: Short stature and slow growth
Treatment phase: Initial treatment
Restriction
Indication: Short stature and slow growth
Treatment phase: Recommencement of treatment
Restriction
Indication: Short stature and slow growth
Treatment phase: Recommencement of treatment as a reclassified patient
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 8 | Max qty units: 8 | # of repeats: 1 | DPMQ: $5,631.64 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Sogroya | |||||